© 2020 MJH Life Sciences and OncLive. All rights reserved.
August 05, 2020
Ruben A. Mesa, MD, discusses mitigating racial disparities in myeloproliferative neoplasm clinical trials.
April 21, 2020
Ruben Mesa, MD, discusses the use of ruxolitinib versus fedratinib in patients with myelofibrosis and baseline thrombocytopenia.
April 11, 2020
Ruben Mesa, MD, discusses unanswered questions regarding JAK inhibitors in myelofibrosis.
April 08, 2020
Ruben Mesa, MD, discusses remaining challenges in treating myelofibrosis.